195 related articles for article (PubMed ID: 24633887)
1. SUZ12 is involved in progression of non-small cell lung cancer by promoting cell proliferation and metastasis.
Liu C; Shi X; Wang L; Wu Y; Jin F; Bai C; Song Y
Tumour Biol; 2014 Jun; 35(6):6073-82. PubMed ID: 24633887
[TBL] [Abstract][Full Text] [Related]
2. Decorin is responsible for progression of non-small-cell lung cancer by promoting cell proliferation and metastasis.
Shi X; Liang W; Yang W; Xia R; Song Y
Tumour Biol; 2015 May; 36(5):3345-54. PubMed ID: 25524578
[TBL] [Abstract][Full Text] [Related]
3. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R
J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193
[TBL] [Abstract][Full Text] [Related]
4. SUZ12 promotes gastric cancer cell proliferation and metastasis by regulating KLF2 and E-cadherin.
Xia R; Jin FY; Lu K; Wan L; Xie M; Xu TP; De W; Wang ZX
Tumour Biol; 2015 Jul; 36(7):5341-51. PubMed ID: 25672609
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
6. Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer.
Lee SR; Roh YG; Kim SK; Lee JS; Seol SY; Lee HH; Kim WT; Kim WJ; Heo J; Cha HJ; Kang TH; Chung JW; Chu IS; Leem SH
Clin Cancer Res; 2015 Dec; 21(23):5391-403. PubMed ID: 26268246
[TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer.
Liu XH; Liu ZL; Sun M; Liu J; Wang ZX; De W
BMC Cancer; 2013 Oct; 13():464. PubMed ID: 24103700
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.
Liu XH; Lu KH; Wang KM; Sun M; Zhang EB; Yang JS; Yin DD; Liu ZL; Zhou J; Liu ZJ; De W; Wang ZX
BMC Cancer; 2012 Aug; 12():348. PubMed ID: 22876840
[TBL] [Abstract][Full Text] [Related]
9. EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer.
Cao W; Ribeiro Rde O; Liu D; Saintigny P; Xia R; Xue Y; Lin R; Mao L; Ren H
PLoS One; 2012; 7(12):e52984. PubMed ID: 23300840
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
12. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
[TBL] [Abstract][Full Text] [Related]
14. MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer.
Ye MF; Zhang JG; Guo TX; Pan XJ
Biomed Pharmacother; 2018 Jan; 97():1289-1295. PubMed ID: 29156517
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-219 is downregulated in non-small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2.
Sun X; Xu M; Liu H; Ming K
Mol Med Rep; 2017 Sep; 16(3):3557-3564. PubMed ID: 28714014
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis.
Lin L; Gu ZT; Chen WH; Cao KJ
Diagn Pathol; 2015 Mar; 10():14. PubMed ID: 25889788
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer.
Chen X; Shao W; Huang H; Feng X; Yao S; Ke H
Hum Pathol; 2019 Jan; 83():140-148. PubMed ID: 30172915
[TBL] [Abstract][Full Text] [Related]
18. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
19. SUZ12 RNA interference inhibits the invasion of gastric carcinoma cells.
Xu XT; Tao ZZ; Song QB; Yao Y; Ruan P
Hepatogastroenterology; 2014; 61(136):2416-20. PubMed ID: 25699394
[TBL] [Abstract][Full Text] [Related]
20. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
Yang J; Du YM; Li B
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]